COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group (2024)
- Authors:
- Autor USP: SHINJO, SAMUEL KATSUYUKI - FM
- Unidade: FM
- DOI: 10.1007/s00296-023-05496-y
- Subjects: COVID-19; DIABETES MELLITUS; VACINAÇÃO; ESTUDOS TRANSVERSAIS
- Language: Inglês
- Imprenta:
- Publisher place: Heidelberg
- Date published: 2024
- Source:
- Título: Rheumatology international
- ISSN: 0172-8172
- Volume/Número/Paginação/Ano: v. 44, n. 1, p. 73-80, 2024
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
PANCHAWAGH, Suhrud et al. COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group. Rheumatology international, v. 44, n. 1, p. 73-80, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/58770. Acesso em: 29 dez. 2025. -
APA
Panchawagh, S., Ravichandran, N., Barman, B., Nune, A., Javaid, M., Gracia-Ramos, A. E., et al. (2024). COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group. Rheumatology international, 44( 1), 73-80. doi:10.1007/s00296-023-05496-y -
NLM
Panchawagh S, Ravichandran N, Barman B, Nune A, Javaid M, Gracia-Ramos AE, Day J, Joshi M, Kuwana M, Shinjo SK. COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group [Internet]. Rheumatology international. 2024 ; 44( 1): 73-80.[citado 2025 dez. 29 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58770 -
Vancouver
Panchawagh S, Ravichandran N, Barman B, Nune A, Javaid M, Gracia-Ramos AE, Day J, Joshi M, Kuwana M, Shinjo SK. COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group [Internet]. Rheumatology international. 2024 ; 44( 1): 73-80.[citado 2025 dez. 29 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58770 - Combined glucosamine and chondroitin sulfate, once or three times daily, provides clinically relevant analgesia in knee osteoarthritis
- Desfechos da gestação em pacientes com dermatomiosite e polimiosite
- Spontaneous pneumomediastinum in dermatomyositis: a case series and literature review
- Mycophenolate mofetil in patients with refractory systemic autoimmune myopathies: case series
- Patients with pure dermatomyositis/polymyositis and anti-PM/Scl autoantibody resembling anti-synthetase syndrome
- Rituximab as a treatment for human immunodeficiency virus-associated nemaline myopathy: What does the literature have to tell us?
- Clinical manifestations, outcomes, and antibody profile of Brazilian adult patients with dermatomyositis: a single-center longitudinal study
- Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study
- COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies
- Breaking the diagnosis. [Editorial]: ankylosing spondylitis evidenced by cervical fracture following spine manipulation
Informações sobre o DOI: 10.1007/s00296-023-05496-y (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
